In the summer of 2016, the Sidney Kimmel Cancer Center at Jefferson once again elevated the level of its Breast Cancer Screening and Treatment Program by welcoming three new members to the breast cancer team. With the Kimmel Cancer Center being a Komen Philadelphia Community Grantee for over a decade, Jefferson’s breast health program has consistently been a major driver of our mission, helping us to save lives every day and bring hope to thousands of women in need.
Komen Philadelphia is excited about the fresh energy these three new additions bring to the breast cancer program at Jefferson. The work of all three new team members, combined with that of other professionals dedicated to the advancing the Jefferson breast program, is helping Komen’s move toward our goal of significantly reducing breast cancer mortality over the next decade. Komen Philadelphia is thrilled to have them as key contributors to our 2nd Annual Metastatic Breast Cancer Symposium, and we look forward to even more great things to come from Jefferson under their leadership.
Maysa Abu-Khalaf, MD, has been appointed to the role of Director of the Breast Medical Oncology Program within the Division of Solid Tumors and Co-Director of the Breast Care Center at the Sidney Kimmel Cancer Center at Jefferson. She joins Jefferson from Yale University where she worked for 11 years as a breast medical oncologist and clinical researcher. Dr. Abu-Khalaf specializes in the management of patients with high risk and advanced breast cancers. As a clinical researcher, she works closely with colleagues at Jefferson and other institutions to evaluate novel therapies as part of clinical trials, and to identify biomarkers that can predict better responses to these treatments. She feels privileged to be part of a team of researchers and clinicians who contribute to advancing research and providing the best of care to our patients. Dr. Abu-Khalaf also wants to encourage more women to come in for their screening mammograms as diagnosing breast cancer at an early stage increases the chance of cure.
Daniel P. Silver, MD, PhD, comes from the Dana-Farber Cancer Institute and has joined the team as Director of Basic Science and Research in Medical Oncology at Thomas Jefferson University and Leader of the Breast Program at Sidney Kimmel Cancer Center. Dr. Silver moved to Jefferson because he saw an opportunity to make an even greater impact for patients living with cancer. He feels that the breast cancer clinical community at Jefferson is completely dedicated to providing the best, highest quality care for patients, and the opportunities to do research and bring promising ideas into clinical trials are tremendous. He has been impressed by the diverse array of skills and talents of his colleagues, and loves the spirit that motivates them.
Associate Professor Nicole L. Simone, MD, who has been a part of the Jefferson community since 2010, has taken on the role of Radiation Director of the Jefferson Breast Center and the Co-Leader of the Breast Program at the Sidney Kimmel Cancer Center. Dr. Simone has a particular interest in performing bench research and taking it directly to her patients to try and eradicate breast cancer. Her laboratory has successfully translated findings at the bench to first-in-human clinical trials using diet to augment radiation or chemotherapy while protecting normal tissues in breast cancers.